Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Alex Varvares, M.D.

Concepts

This page shows the publications Mark Varvares has written about Survival Analysis.
Connection Strength

0.401
  1. Preoperative laboratory data are associated with complications and surgical site infection in composite head and neck surgical resections. Am J Otolaryngol. 2018 May - Jun; 39(3):261-265.
    View in: PubMed
    Score: 0.069
  2. Decreased cancer-independent life expectancy in the head and neck cancer population. Head Neck. 2017 09; 39(9):1845-1853.
    View in: PubMed
    Score: 0.066
  3. Competing causes of death in the head and neck cancer population. Oral Oncol. 2017 02; 65:8-15.
    View in: PubMed
    Score: 0.064
  4. Predictors of stage at presentation and outcomes of head and neck cancers in a university hospital setting. Head Neck. 2016 04; 38 Suppl 1:E1826-32.
    View in: PubMed
    Score: 0.059
  5. Improved overall survival and mortality in head and neck cancer with adjuvant concurrent chemoradiotherapy in national databases. Head Neck. 2016 Feb; 38(2):208-15.
    View in: PubMed
    Score: 0.057
  6. PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient. Laryngoscope. 2013 Sep; 123(9):2161-4.
    View in: PubMed
    Score: 0.050
  7. Histological pattern of mandibular invasion by oral squamous cell carcinoma. Laryngoscope. 2000 Jan; 110(1):65-72.
    View in: PubMed
    Score: 0.020
  8. Primary Cancer vs Competing Causes of Death in Survivors of Head and Neck Cancer. JAMA Oncol. 2018 Feb 01; 4(2):257-259.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.